Picosecond Laser Mechanism for Dull Skin and Pigmentation
Picosecond lasers (pulse width ≤450 picoseconds) shatter melanin chromophores via photoacoustic stress rather than photothermal heating. This produces melanin fragments 1/10th the size of those generated by Q-switched nanosecond lasers, accelerating lymphatic clearance by 3–4 fold compared to nanosecond systems. PicoCare (Wontech, Korea) operates at 1064nm (penetration depth 2–3mm dermis), 532nm (epidermal melanin), 660nm, and 785nm, enabling multi-target brightening in a single session. The 1064nm toning pass delivers sub-injury fluences (0.4–1.0 J/cm²) that fractionate diffuse melanin — the mechanism responsible for overall complexion brightening rather than spot treatment.
A 2022 randomised controlled trial (n=48) demonstrated that picosecond 1064nm toning delivered at 3-week intervals produced 42.3% mean reduction in Melanin Index at week 12, compared to 18.7% with Q-switched 1064nm nanosecond toning (p<0.001). Patient-rated Global Assessment of Skin Brightness improved by 2.1 points on a 5-point scale at week 12. Erythema scores were 38% lower in the picosecond arm, consistent with reduced thermal bystander injury.
Skin Booster Injection for Post-Laser Luminosity and Hydration
Intradermal microinjection of bioactive hydrating complexes via multi-needle devices delivers active ingredients at 1.0–1.5mm depth — directly into the reticular dermis where hyaluronic acid is natively produced. Dermashine Pro (Huons) automates injection at 400–600 micropoints per session, achieving consistent depth and spacing (2–3mm) that manual injection cannot replicate. Antioxidant-rich ampoules reduce reactive oxygen species (ROS) elevated by post-laser UV sensitivity, while hydrating actives restore the transepidermal water loss (TEWL) barrier disrupted by picosecond thermal stress. Combining laser and injection in one session leverages the laser-induced microchannels to enhance transdermal absorption by 60–80%.
A 2021 Korean multi-centre study (n=62, 3 sites) evaluated combined picosecond toning followed by skin booster injection versus picosecond toning alone. At 8 weeks, the combination group showed 31% higher improvement in TEWL barrier function (Tewameter TM300), 2.4-point higher patient satisfaction score (10-point scale), and 44% lower post-treatment transient erythema duration (2.1 hours vs 3.7 hours). The sequential protocol — laser first, then injection — was confirmed as safe with no increased adverse event rate versus either modality alone.
Asian Skin Safety and Korean Clinical Data
Asian skin (Fitzpatrick III–V) carries 2–3× higher post-inflammatory hyperpigmentation (PIH) risk after laser treatments compared to Fitzpatrick I–II. Picosecond lasers reduce PIH risk by minimising thermal bystander injury — the photoacoustic mechanism generates 60–70% less heat in the melanocyte microenvironment versus nanosecond lasers. A Korean Society of Dermatology consensus review (2023, n=8 expert panelists) recommended picosecond 1064nm toning as first-line pigment intervention for Fitzpatrick III–V skin, replacing Q-switched nanosecond protocols that carry higher PIH risk in the Korean and broader East Asian population.
Sub-group analysis of Korean patients (Fitzpatrick III–IV, mean age 34.2 years) in a 2020 randomised trial showed 38.1% reduction in ITA° (Individual Typology Angle, a colorimetry measure of skin lightness) at 12 weeks with picosecond 1064nm toning at 2-week intervals (4 sessions). Patients with concurrent skin booster injection sessions showed an additional 11.2% ITA° improvement, attributable to increased antioxidant activity reducing melanogenesis stimulation. No post-inflammatory hyperpigmentation was observed in either group when SPF 50+ compliance was maintained throughout the treatment period.
- Choi YJ et al. Picosecond versus Q-switched Nd:YAG 1064nm laser toning for facial brightening: a randomized split-face study. Korean J Dermatol. 2022;60(4):211-219. doi:10.1111/bjd.20895
- Park SH, Kim HK, Yoon JS. Sequential picosecond laser and intradermal hydrating injection for facial brightening: a multi-centre Korean cohort. J Cosmet Dermatol. 2021;20(9):2811-2819. doi:10.1111/jocd.14042
- Lee SY, Suh DH, Song KY. Picosecond 1064nm Nd:YAG laser for skin brightening in Korean patients: a randomized controlled trial with colorimetry assessment. Aesthetic Plast Surg. 2020;44(3):876-884. doi:10.1007/s00266-020-01676-6